Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses
International Forum of Allergy & Rhinology · 2026-08 · 16 (8) · 831-840
DOI: 10.1002/alr.70126 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 05.03.2026. Verfasst von Rui Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Endoscopy, Radiofrequency Ablation, Rhinitis, Allergic, Nose. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Medical Scientific Research Foundation of Guangdong Province of China.
Abstract (Originalsprache)
Background
Endoscopic posterior nasal nerve (PNN) neurectomy and temperature‐controlled radiofrequency ablation are validated interventions for medication‐refractory allergic rhinitis (AR), but direct comparisons of their long‐term efficacy, safety, and mechanisms remain lacking.
Methods
In this prospective, multicenter, randomized, patient‐blinded study, 174 adults with moderate‐to‐severe persistent AR were allocated to PNN neurectomy ( n = 89) or ablation ( n = 85). The primary endpoint was the percentage of participants achieving the minimal clinically important difference (MCID) for the 24‐h reflective total nasal symptom score (rTNSS) at 24 months.
Results
The rTNSS MCID responder rate at 24 months was 86.5% (95% confidence interval [CI], 80.0–95.0%) in the neurectomy group and 84.9% (95% CI, 78.0–94.0%) in the ablation group, with no significant between‐group difference ( p = 0.453). Both groups demonstrated substantial and parallel improvements in quality of life. Neurectomy provided greater and more durable control of rhinorrhea (1–24 months, all p < 0.05), nasal congestion (24 months, p < 0.001), and nasal itching (24 months, p = 0.046), alongside a greater reduction in unilateral nasal resistance (right side, p = 0.014). Both groups showed convergent systemic neuroimmune reprogramming at 1 year, with suppression of substance P, interleukin (IL)‐31, IL‐33, IL‐4, IL‐13, and IL‐6, and increased transforming growth factor‐β (TGF‐β)and immunoglobulin G4 (IgG4). No serious adverse events occurred; mild transitory events were reported only with neurectomy (3.4%).
Conclusion
Both techniques are effective and safe for refractory AR over 2 years. Although overall outcomes are comparable, neurectomy offers superior and sustained control of rhinorrhea, nasal congestion, and nasal itching. Treatment can be individualized based on symptom profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Allergy, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Key Laboratory of Airway Inflammatory Disease Research and Innovative Technology Translation, Guangzhou, China.
- Department of Otolaryngology, First People's Hospital of Foshan, Foshan, China.
- Department of Otolaryngology Head and Neck Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Otolaryngology Head and Neck Surgery, China-Japan Friendship Hospital, Beijing, China.
ORCID-Profile: Shuo Wu, Zhaohui Shi, Shaoqing Yu, Qintai Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Medical Scientific Research Foundation of Guangdong Province of China
- Science and Technology Projects in Guangzhou
- Science and Technology Projects in Shenzhen
Zitieren
APA
Zheng, R., Huang, X., Wu, S., Shi, Z., Wang, K., Qiu, H., Yuan, T., Zhao, C., Zhao, J., Wang, W., Xiao, Z., Liu, J., Yu, S., & Yang, Q. (2026). Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses. International Forum of Allergy & Rhinology, 16(8), 831-840. https://doi.org/10.1002/alr.70126
Vancouver
Zheng R, Huang X, Wu S, Shi Z, Wang K, Qiu H, et al. Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses. International Forum of Allergy & Rhinology. 2026;16(8):831-840. doi:10.1002/alr.70126
BibTeX
@article{Zheng2026,
author = {Zheng, Rui and Huang, Xuekun and Wu, Shuo and Shi, Zhaohui and Wang, Kai and Qiu, Huijun and Yuan, Tian and Zhao, Chuanliang and Zhao, Jianhui and Wang, Weihao and Xiao, Zhenhao and Liu, Jianfeng and Yu, Shaoqing and Yang, Qintai},
title = {Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
volume = {16},
number = {8},
pages = {831--840},
doi = {10.1002/alr.70126}
}
EUVIMED